This third annual survey of the MedComms Networking Community will run throughout January (closing date 31 January 2018). Note participation is on an entirely anonymous basis and the results will then be made freely available to all.

This is not intended as a robust study but will hopefully provide a useful annual barometer of sentiment amongst our specialist community, which will provide a valuable insight into the development and maturity of this important business over time.

The survey is designed such that most participants will complete the survey in only 10 minutes or so. Please answer as honestly and fully as possible.

The survey data will be available to browse after 31 January 2018, from the MedComms Networking Surveys page where copies of previous surveys are freely available.

This survey is being managed by Peter Llewellyn of NetworkPharma Ltd. If you have any questions at any time, or any comments you would prefer to be kept private, please don't hesitate to email peter@networkpharma.com

* 1. Where are you based (tick one answer)?

* 2. What best describes where you currently work (we appreciate there will be some overlap of roles and nomenclature but please tick one “best” answer)?

* 3. What is the best fit, broad description, of your primary role (we appreciate there will be some overlap of roles and nomenclature but please tick one “best” answer)?

* 5. Which of the following specialist MedComms areas are you currently active in (tick all that apply)?

* 6. Where do you work from primarily?

* 7. How satisfied are you with your current job?

* 8. How likely is it that you will look to change your employer in 2018 (freelancers, you are your own employer)?

* 9. From your own perspective, do you think the overall amount of MedComms activity that the Pharma/Healthcare/Biotech/Devices industry is outsourcing year on year is currently...

* 10. From your own perspective, comparing 2018 vs 2017 do you think the overall amount of consolidation/M&A activity amongst MedComms agencies will...

* 11. From your own perspective, comparing 2018 vs 2017 do you think the overall amount of consolidation/M&A activity amongst Pharma/Healthcare/Biotech/Devices companies will...

* 12. How much do you agree with the following statements? Please answer from a personal viewpoint (read carefully - tick one answer for each statement).

  I don't agree at all 0 1 2 3 4 5 6 7 8 I entirely agree 9
The pharma industry is a credible and trusted source of information about medicines
It is a good principle to aim at, to publish all clinical trial data for all products
The pharma industry is indeed striving to publish all clinical trial data for all products
MedComms specialists can play a direct role in ensuring pharma companies work to best practice standards
The reputation of the pharmaceutical industry is improving amongst the wider public
The reputation of the pharmaceutical industry is improving amongst healthcare professionals
Total transparency of financial arrangements between industry and healthcare professionals is a good principle to aim at
MedComms is an ethical business
I am confident about my personal financial future
I can easily meet my current training needs
I believe my employer (or in the case of Freelancers - I) will increase revenues in 2018 compared with 2017
I believe my employer (or in the case of Freelancers - I) will increase profitability in 2018 compared with 2017

* 13. If asked, do you recommend MedComms to others as a worthwhile career option?

* 14. Do you have any general comments at all to offer about the current state of the MedComms business, the Pharma industry, this survey or about life in general? All comments welcomed.  Please remember the comments here will be made public.

* 15. What, if any, thoughts have you about topics you would like to see covered by MedComms Networking events over the coming 12 months? All suggestions welcomed. Please remember the comments here will be made public.

T